ISFAHAN UNIVERSITY OF MEDICAL SCIENCES

ISFAHAN UNIVERSITY OF MEDICAL SCIENCES logo
🇮🇷Iran
Ownership
Private
Established
1024-01-01
Employees
-
Market Cap
-
Website
http://www.mui.ac.ir
Clinical Trials
Related News

Effect of Lidocaine/Dexamethasone on the Success of IANB

Phase 2
Completed
Conditions
Local Anesthesia
Interventions
Drug: Dexamethasone
Drug: Placebo
First Posted Date
2018-05-22
Last Posted Date
2018-05-22
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
100
Registration Number
NCT03531970
Locations
🇮🇷

Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of

Low-Dose Intravenous Ketamine Bolus Versus Conventional Technique

First Posted Date
2018-04-17
Last Posted Date
2018-04-17
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
198
Registration Number
NCT03499886
Locations
🇮🇷

Al-Zahra University Hospital, Isfahan, Iran, Islamic Republic of

🇮🇷

Mehdi Nasr Isfahani, Isfahan, Iran, Islamic Republic of

The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy

First Posted Date
2018-03-15
Last Posted Date
2018-03-15
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
126
Registration Number
NCT03466645
Locations
🇮🇷

Isfahan university of medical science., Isfahan, Iran, Islamic Republic of

Buspirone Plus Omeprazole for Functional Dyspepsia

Phase 4
Completed
Conditions
Dyspepsia
Interventions
Drug: Placebo Oral Tablet
Drug: Buspirone
First Posted Date
2018-02-23
Last Posted Date
2018-02-23
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
70
Registration Number
NCT03444831

Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction

First Posted Date
2018-01-23
Last Posted Date
2018-08-20
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
70
Registration Number
NCT03405207
Locations
🇮🇷

Cardiovascular Rehabilitation Research Center, Isfahan, Iran, Islamic Republic of

Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke

Phase 1
Conditions
Cerebrovascular Disorders
Interventions
Biological: exosome
First Posted Date
2017-12-27
Last Posted Date
2021-01-25
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
5
Registration Number
NCT03384433
Locations
🇮🇷

Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of

Bier's Block Versus Systemic Analgesia

First Posted Date
2017-11-21
Last Posted Date
2017-11-21
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
70
Registration Number
NCT03349216
Locations
🇮🇷

Al-Zahra Hospital, Isfahan, Iran, Islamic Republic of

Fiber and Cardiovascular Risk Factors

Not Applicable
Completed
Conditions
Cardiovascular Risk Factor
Interventions
Dietary Supplement: fiber
First Posted Date
2017-11-13
Last Posted Date
2019-09-20
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
75
Registration Number
NCT03340298

Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients

First Posted Date
2017-10-20
Last Posted Date
2019-05-23
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
84
Registration Number
NCT03315923
Locations
🇮🇷

Kashani Hospital, Isfahan, Iran, Islamic Republic of

Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)

First Posted Date
2017-09-06
Last Posted Date
2019-03-27
Lead Sponsor
Isfahan University of Medical Sciences
Target Recruit Count
20
Registration Number
NCT03272802
Locations
🇮🇷

EMG Department, Alzahra Hospital, Isfahan, Iran, Islamic Republic of

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy